Simultaneous signalling through c‐mpl, c‐kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3‐K, PKC and MAPK pathways
Open Access
- 1 October 2001
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 115 (1) , 175-185
Abstract
We assessed the effect of signalling through CXCR4 on the proliferation and differentiation of human megakaryocytic progenitor cells (CFU‐Meg) in the presence or absence of stem cell factor (SCF) and/or thrombopoietin (TPO), using peripheral blood‐derived CD34+IL‐6R− cells as a target. TPO alone induced a significant number of CFU‐Meg colonies. Although stromal cell‐derived factor‐1 (SDF‐1) or SCF alone did not support CFU‐Meg colony formation, these factors had a synergistic effect on CFU‐Meg colony formation in the presence of TPO. The combination of SDF‐1, SCF and TPO induced twice as many CFU‐Meg colonies as TPO alone. To investigate the mechanism of this synergistic action, we examined the effects of various protein kinase inhibitors on CFU‐Meg colony formation. LY294002 and GF109203X (inhibitors of PI3‐K and PKC respectively) completely or partially inhibited this synergistic action. In contrast, a MEK inhibitor (PD98059) did not inhibit CFU‐Meg colony formation. It significantly increased the higher ploidy classes (16N to 64N) of megakaryocytes supported by TPO, TPO + SCF, TPO + SDF‐1, and TPO + SCF + SDF‐1, whereas it abolished the effect of SDF‐1 on the increase of higher ploidy classes of megakaryocytes supported by TPO. These results suggest that MAPK may negatively or positively regulate the nuclear maturation of megakaryocytes, known as endomitosis. In the presence of PD98059, proplatelet formation (PPF) was significantly augmented, suggesting that the MAPK pathway may also inhibit the initiation of PPF. In conclusion, simultaneous activation of three signals through c‐mpl, c‐kit and CXCR4 can induce the in vitro proliferation and differentiation of CFU‐Meg, and SDF‐1 is a potentiator of human megakaryocytopoiesis.Keywords
This publication has 31 references indexed in Scilit:
- Interleukin 6 receptor expression by human cord blood‐ or peripheral blood‐derived primitive haematopoietic progenitors implies acquisition of different functional propertiesBritish Journal of Haematology, 2000
- The Role of HIV‐Related Chemokine Receptors and Chemokines in Human Erythropoiesis in VitroStem Cells, 2000
- Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survivalBlood, 2000
- Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK)Blood, 2000
- Thrombopoietin can influence mature megakaryocytes to undergo further nuclear and cytoplasmic maturationExperimental Hematology, 2000
- Biology and mechanisms of action of synergistically stimulated myeloid progenitor cell proliferation and suppression by chemokinesStem Cells, 1997
- The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesisBritish Journal of Haematology, 1996
- Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.Proceedings of the National Academy of Sciences, 1995
- Development of a tissue culture assay system for Campylobacter jejuni cytotoxin and the influence of culture conditions on cytotoxin productionJournal of Medical Microbiology, 1994
- Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.Proceedings of the National Academy of Sciences, 1988